Cerus News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

20.06.16	CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017 (RTTNews)
17.03.16	GLPG Awaits SAPHIRA Data, VTAE Vaults, CBLI Hits A Snag (RTTNews)
04.03.16	CERS Gets A Lift From Blood Bank Deal, VTAE On Track, TBRA Awaits Data In Q2 (RTTNews)
05.01.15	Cerus: EU Phase 3 Study Of INTERCEPT Red Blood Cells Meets Primary Endpoint (RTTNews)
22.12.14	Cerus U.S. Phase 2 Trial Of INTERCEPT Red Blood Cells Meets Primary Endpoint (RTTNews)
19.12.14	Cerus Surges As FDA Approves INTERCEPT Blood System For Platelets (RTTNews)
17.12.14	ASPX Flies On Trial Data, CYCC Knocked Down, NVGN Creates Buzz, BVX On Watch (RTTNews)
17.12.14	Cerus : FDA Oks Pathogen Reduction System To Treat Plasma (RTTNews)
21.11.14	Cerus: FDA Accepts IDE Supplement For INTERCEPT Blood System In Ebola Plasma (RTTNews)
07.10.14	Cerus Says FDA Accepts IDE Submission For INTERCEPT - Quick Facts (RTTNews)
01.08.14	ALXA Working Its Way, CERS Awaits FDA Decision, XNCR, SGEN Look Ahead To Results (RTTNews)
26.02.14	ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High (RTTNews)
02.10.13	ANAC, SLXP Get FDA Date, CERS On A High, MACK On Watch, OGEN And XON Team Up (RTTNews)
09.02.10	Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Development (Businesswire)
14.01.10	Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets (Businesswire)
02.06.09	Cerus and Grifols to Collaborate on INTERCEPT Red Cell Kit Development (Businesswire)
24.02.09	Cerus Announces Marketing Authorization Granted to Largest Region of German Red Cross (Businesswire)
23.10.08	Bacterial Risks Prompt German Safety Measures (Businesswire)
29.01.07	Cerus' INTERCEPT Blood System Receives First Approval in Germany (Businesswire)
03.05.05	Cerus Corporation Announces First Quarter Financial Results (Businesswire)
19.04.05	Cerus to Present at American Association for Cancer Research Annual Me (Businesswire)
03.02.05	Cerus Corporation Announces Fourth Quarter and Year-End Results (Businesswire)
28.01.05	C. Raymond Larkin, Jr. Resigns from Cerus Board of Directors (Businesswire)
19.01.05	Cerus Corporation to Webcast Fourth Quarter and Year-End Financial Res (Businesswire)
05.01.05	Cerus and BioOne Sign Letter of Intent for Commercialization of INTERC (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.04	2.41 %	K V
ABB	52.12	1.68 %	K V
Geberit	552.80	1.32 %	K V
Alcon	78.04	1.19 %	K V
CieFinRichemont	129.05	1.10 %	K V
Swiss Life Hldg	686.00	-0.64 %	K V
Zurich Insur Gr	555.20	-1.00 %	K V
Holcim	90.66	-1.31 %	K V
Kuehne+Nagel Int	210.60	-1.31 %	K V
Novartis	90.10	-3.14 %	K V

mehr

03.12.24		Aufschläge in New York: NASDAQ Composite beendet den Handel mit Gewinnen
03.12.24		Zurückhaltung in New York: NASDAQ Composite zum Start leichter
02.12.24		NASDAQ-Handel: NASDAQ Composite liegt zum Start des Montagshandels im Plus
27.11.24		Schwacher Wochentag in New York: NASDAQ Composite verbucht zum Handelsstart Verluste
22.11.24		NASDAQ-Handel: NASDAQ Composite letztendlich fester
22.11.24		Starker Wochentag in New York: NASDAQ Composite am Nachmittag auf grünem Terrain
15.11.24		Schwacher Wochentag in New York: NASDAQ Composite präsentiert sich zum Start leichter
12.11.24		Minuszeichen in New York: NASDAQ Composite notiert am Nachmittag im Minus